Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedRadio: NanoViricides CEO Discusses U.S. Patent
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Editor’s Note May 22, 2012
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face of patient billing. Opexa CEO, Neil Warma […]
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The Technology Corner: Disruptive Technology for Prostate Cancer
In this special series we present emerging technologies which hold the promise to significantly improve the prognosis of patients diagnosed with prostate cancer, and cancer in general.
“Rockstar of Science”, Eric Topol M.D. Talks The Creative Destruction of Medicine
Author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare”, Dr. Eric Topol sits down with OneMedRadio to discuss the ideas and inspiration behind the book.
NYBA Annual Meeting: The Wrap Up
The New York Biotech Association Annual Meeting last Wednesday and Thursday was a success, showcasing 15 emerging companies as well as two dozen panels over the two-day span. Held in the Marriott Marquis Hotel, a staple of Times Square, the 21st annual conference was well attended.
CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer
Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.
